Thymic abnormalities in rare immunological diseases

Description of the granted funding

Many rare diseases are caused by a malfunctioning immune system, which attacks the patient's own tissues in a process called autoimmunity. The treatment options are limited by the fact that the origin of such autoimmune attack is poorly understood. In the TARID project we study two rare diseases, Myasthenia gravis and APECED, which have as unifying features an inherited or acquired defect in Autoimmune Regulator (AIRE) -gene and the patients also share specific types of autoantibodies. AIRE normally works in the thymus, the organ responsible for generating T cells, key immune cells responsible for cellular immunity and immune regulation. Somehow the AIRE-deficiency also leads to production of high-affinity antibodies against self-antigens. The main aim of TARID consortium is to characterize how the loss of AIRE leads to autoantibody production. These results can elucidate also pathogenesis more common autoimmune diseases where autoantibodies are produced.
Show more

Starting year

2020

End year

2023

Granted funding


Petteri Arstila
127 759 €

Role in consortium of the Academy of Finland

Partner

Other consortium parties

Leader
University of Helsinki (334812)
127 765 €

Funder

Research Council of Finland

Funding instrument

Kansainvälinen yhteisrahoitteinen ohjelma

Other information

Funding decision number

334813

Fields of science

Biomedicine

Research fields

Biolääketieteet

Identified topics

genes, genetics